Feller DR - Search Results

1

Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids.

Intrasuksri U, Rangwala SM, O'Brien M, Noonan DJ, Feller DR. Intrasuksri U, et al. Among authors: feller dr. Gen Pharmacol. 1998 Aug;31(2):187-97. doi: 10.1016/s0306-3623(98)00029-9. Gen Pharmacol. 1998. PMID: 9688458

2

Structural requirements of chiral clofibric acid analogs for activation of the rat peroxisome proliferator-activated receptor alpha.

Feller DR, O'Brien M, Rangwala SM, Tortorella V, Loiodice F, Noonan DJ. Feller DR, et al. Ann N Y Acad Sci. 1996 Dec 27;804:713-5. doi: 10.1111/j.1749-6632.1996.tb18677.x. Ann N Y Acad Sci. 1996. PMID: 8993602 No abstract available.

3

Stereoselective effects of chiral clofibric acid analogs on rat peroxisome proliferator-activated receptor alpha (rPPAR alpha) activation and peroxisomal fatty acid beta-oxidation.

Rangwala SM, O'Brien ML, Tortorella V, Longo A, Loiodice F, Noonan DJ, Feller DR. Rangwala SM, et al. Among authors: feller dr. Chirality. 1997;9(1):37-47. doi: 10.1002/(SICI)1520-636X(1997)9:1<37::AID-CHIR8>3.0.CO;2-D. Chirality. 1997. PMID: 9094202

4

Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin.

Jaradat MS, Wongsud B, Phornchirasilp S, Rangwala SM, Shams G, Sutton M, Romstedt KJ, Noonan DJ, Feller DR. Jaradat MS, et al. Among authors: feller dr. Biochem Pharmacol. 2001 Dec 15;62(12):1587-95. doi: 10.1016/s0006-2952(01)00822-x. Biochem Pharmacol. 2001. PMID: 11755111

5

Comparison of the effects of selected monocarboxylic, dicarboxylic and perfluorinated fatty acids on peroxisome proliferation in primary cultured rat hepatocytes.

Intrasuksri U, Feller DR. Intrasuksri U, et al. Among authors: feller dr. Biochem Pharmacol. 1991 Jun 21;42(1):184-8. doi: 10.1016/0006-2952(91)90698-5. Biochem Pharmacol. 1991. PMID: 2069591 No abstract available.

6

Pseudolaric acid analogs as a new class of peroxisome proliferator-activated receptor agonists.

Jaradat MS, Noonan DJ, Wu B, Avery MA, Feller DR. Jaradat MS, et al. Among authors: feller dr. Planta Med. 2002 Aug;68(8):667-71. doi: 10.1055/s-2002-33785. Planta Med. 2002. PMID: 12221584

7

Convergence of three steroid receptor pathways in the mediation of nongenotoxic hepatocarcinogenesis.

O'Brien ML, Rangwala SM, Henry KW, Weinberger C, Crick DC, Waechter CJ, Feller DR, Noonan DJ. O'Brien ML, et al. Among authors: feller dr. Carcinogenesis. 1996 Feb;17(2):185-90. doi: 10.1093/carcin/17.2.185. Carcinogenesis. 1996. PMID: 8625436

8

In vivo and in vitro peroxisome proliferation properties of selected clofibrate analogues in the rat. Structure-activity relationships.

Esbenshade TA, Kamanna VS, Newman HA, Tortorella V, Witiak DT, Feller DR. Esbenshade TA, et al. Among authors: feller dr. Biochem Pharmacol. 1990 Sep 15;40(6):1263-74. doi: 10.1016/0006-2952(90)90392-x. Biochem Pharmacol. 1990. PMID: 2403380

9

Quantitative assessment of enzyme induction by peroxisome proliferators and application to determination of effects on triglyceride biosynthesis in primary cultures of rat hepatocytes.

Kocarek TA, Feller DR. Kocarek TA, et al. Among authors: feller dr. Biochem Pharmacol. 1989 Dec 1;38(23):4169-76. doi: 10.1016/0006-2952(89)90511-x. Biochem Pharmacol. 1989. PMID: 2597188

10

Beta-adrenergic receptor and platelet inhibitory activities of a new series of trimetoquinol and related benzazepine analogs.

Shams G, Romstedt KJ, Lust LA, Clark MT, Miller DD, Feller DR. Shams G, et al. Among authors: feller dr. Gen Pharmacol. 1997 Feb;28(2):323-30. doi: 10.1016/s0306-3623(96)00223-6. Gen Pharmacol. 1997. PMID: 9013212

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters